Stock Comparison
ARGX vs BNTX
argenx NV ADR and BioNTech SE side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$53.23B
$23.36B
P/E (TTM)
32.7
—
Forward P/E
30.4
7.0
Price/Sales
10.0
8.8
Price/Book
6.4
1.1
EV/EBITDA
27.6
32.5
Dividend Yield
—
—
Profitability
Net Margin
30.44%
-44.95%
Operating Margin
27.34%
-51.83%
Return on Equity
23.60%
-9.30%
Return on Assets
11.60%
-5.41%
Growth (YoY)
Revenue Growth
59.30%
-59.50%
Earnings Growth
95.20%
-43.20%
Price & Risk
Beta
-0.0
1.3
52-Week High
$939.68
$119.34
52-Week Low
$652.43
$83.89
Analyst Target
$1,085.78
$120.75
Compare ARGX and BNTX your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.